Inventor · disambiguated record
Qiang Cong
Also filed as: CONG QIANG
13 granted patents·6 pending applications·146 citations·filing 2005–2023
92Inventor score
Top patents by PatentIndex Score
19 records- 0197US8980824B2Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 17, 2015·35 cites·19 claims
- 0295US8394922B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofCHENG HENG·Filed 2010·Granted Mar 12, 2013·67 cites·26 claims
- 0393US9109008B2Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 18, 2015·7 cites·2 claims
- 0491US9382289B2Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 5, 2016·5 cites·7 claims
- 0591US8802632B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofMEDAREX INC·Filed 2013·Granted Aug 12, 2014·12 cites·13 claims
- 0689US9580467B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofSQUIBB & SONS LLC·Filed 2015·Granted Feb 28, 2017·5 cites·1 claims
- 0786US9688721B2Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 27, 2017·2 cites·1 claims
- 0885US7576094B2Spiro derivatives as lipoxygenase inhibitorsLILLY CO ELI·Filed 2005·Granted Aug 18, 2009·9 cites·37 claims
- 0980US9226974B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofSQUIBB & SONS LLC·Filed 2014·Granted Jan 5, 2016·2 cites·8 claims
- 1075US8772542B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofMEDAREX INC·Filed 2013·Granted Jul 8, 2014·1 cites·10 claims
- 1175US8772543B2Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereofMEDAREX INC·Filed 2013·Granted Jul 8, 2014·1 cites·15 claims
- 1266US2025340510A1Substituted Phenylbenzenesulfonamide Derivatives and Uses ThereofNINE SQUARE THERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 1364US2017260232A1Tubulysin compounds, methods of making and useBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 1455US12485123B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 2, 2025·0 cites·10 claims
- 1553US2023140430A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1652US2023127326A1C3-SUBSTITUTED 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1752US2023144824A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1842US2017326249A1Antibody-drug conjugate of an anti-glypican-3 antibody and a tubulysin analog, preparation and usesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 1939US10279049B2Antibody-drug conjugates of tubulysin analogs with enhanced stabilityBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 7, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Qiang Cong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →